These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Estradiol, estrone, and gonadotropin levels after use of vaginal estradiol. Martin PL; Greaney MO; Burnier AM; Brooks PM; Yen SS; Quigley ME Obstet Gynecol; 1984 Apr; 63(4):441-4. PubMed ID: 6422370 [TBL] [Abstract][Full Text] [Related]
4. Influence of thyrotropin-releasing hormone on the postmenopausal female. Lee SG; Lundy LE; Kashef M; Dorn J Obstet Gynecol; 1975 Jan; 45(1):25-6. PubMed ID: 803307 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505 [TBL] [Abstract][Full Text] [Related]
6. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia. Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524 [TBL] [Abstract][Full Text] [Related]
7. Clinical and endocrine studies in menopausal women after estradiol pellet implantation. Nagamani M; Lin TJ; McDonough PG; Watatani H; McPherson JC; Mahesh VB Obstet Gynecol; 1977 Nov; 50(5):541-7. PubMed ID: 909658 [TBL] [Abstract][Full Text] [Related]
8. [Estradiol-17beta, estrone, LH and FSH in serum after administration of estradiol-17beta, estradiolbenzoate, estradiol-valeriate and estradiol-undecylate in the female (author's transl)]. Leyendecker G; Geppert G; Nocke W; Ufer J Geburtshilfe Frauenheilkd; 1975 May; 35(5):370-4. PubMed ID: 1150068 [TBL] [Abstract][Full Text] [Related]
9. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women. Usuki S; Kondoh K; Kubo T J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439 [TBL] [Abstract][Full Text] [Related]
10. Sublingual absorption of micronized 17beta-estradiol. Burnier AM; Martin PL; Yen SS; Brooks P Am J Obstet Gynecol; 1981 May; 140(2):146-50. PubMed ID: 6786097 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of a new conjugated oral estrogen, estradiol-3beta-glucoside, with oral micronized 17beta-estradiol in postmenopausal women. Sweeney AT; Tangpricha V; Weinberg J; Malabanan AO; Chimeh FN; Holick MF Transl Res; 2006 Oct; 148(4):164-70. PubMed ID: 17002918 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol. Setnikar I; Rovati LC; Vens-Cappell B; Hilgenstock C Arzneimittelforschung; 1996 Aug; 46(8):766-73. PubMed ID: 9125276 [TBL] [Abstract][Full Text] [Related]
13. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs. Lasley BL; Wang CF; Yen SS J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551 [TBL] [Abstract][Full Text] [Related]
14. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix). Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507 [TBL] [Abstract][Full Text] [Related]
15. A gonadotropin and alpha-subunit suppression test for the assessment of the ectopic production of human chorionic gonadotropin and its subunits after the menopause. Papapetrou PD; Anagnostopoulos NI J Clin Endocrinol Metab; 1985 Jun; 60(6):1187-95. PubMed ID: 3923023 [TBL] [Abstract][Full Text] [Related]
17. Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion. Bray MJ; Vick TM; Shah N; Anderson SM; Rice LW; Iranmanesh A; Evans WS; Veldhuis JD J Clin Endocrinol Metab; 2001 Jul; 86(7):3143-9. PubMed ID: 11443179 [TBL] [Abstract][Full Text] [Related]
18. Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration. De Lignieres B; Basdevant A; Thomas G; Thalabard JC; Mercier-Bodard C; Conard J; Guyene TT; Mairon N; Corvol P; Guy-Grand B J Clin Endocrinol Metab; 1986 Mar; 62(3):536-41. PubMed ID: 3080464 [TBL] [Abstract][Full Text] [Related]
19. Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women. Luisi M; Franchi F; Argenio GF; Barletta D; Romano MR; Bernini GP; Gasperi M; Sgrilli R Int J Tissue React; 1981 Jun; 3(2):77-81. PubMed ID: 6799393 [TBL] [Abstract][Full Text] [Related]
20. Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure. Steingold KA; Matt DW; DeZiegler D; Sealey JE; Fratkin M; Reznikov S J Clin Endocrinol Metab; 1991 Aug; 73(2):275-80. PubMed ID: 1906893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]